Author： Grassi Guido
Publisher： Adis International
ISSN： 1120-9879
Source： High Blood Pressure & Cardiovascular Prevention, Vol.15, Iss.3, 2008-01, pp. : 117-119
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
According to the recommendations of the European Society of Hypertension/European Society of Cardiology guidelines on the diagnosis and management of hypertension, the major benefits of antihypertensive treatment are related to blood pressure reduction per se rather than to the specific drugs used. This article reviews this statement by discussing the evidence provided by a number of clinical trials that blood pressure reduction is more important than the antihypertensive drug choice in uncomplicated hypertensive patients. The difference between drugs will become increasingly important as the cardiovascular risk profile of the patient becomes elevated and/or when associated risk factors or concomitant target organ damage are detected.Received for publication 9 June 2008; accepted for publication 10 July 2008.Key words: antihypertensive treatment, monotherapy, combination treatment, cardiovascular risk, hypertension guidelines.
Related content
Access to resources
Recommend
By Prandin Maria Grazia Cicero Arrigo Veronesi Maddalena Cosentino Eugenio Dormi Ada Strocchi Enrico Borghi Claudio
Clinical and Experimental Hypertension, Vol. 29, Iss. 8, 2007-11 ,pp. :